111 related articles for article (PubMed ID: 7530703)
21. [Primary hepatic non-Hodgkin's lymphoma].
De la Maya MD; Escalante R; Torre A; Urdambidelus C
Sangre (Barc); 1999 Jun; 44(3):242. PubMed ID: 10481592
[No Abstract] [Full Text] [Related]
22. Primary non-Hodgkin's lymphoma of the liver.
Czerniak A; Soreide O; Halnan K; Krausz T; Edwards WH; Blumgart LH
Eur J Surg Oncol; 1987 Jun; 13(3):251-5. PubMed ID: 3297793
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M
Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226
[TBL] [Abstract][Full Text] [Related]
24. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
[TBL] [Abstract][Full Text] [Related]
25. [Radiation therapy of localized diffuse large B-cell lymphoma].
Itami J
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Feb; 63(3):89-92. PubMed ID: 12692962
[TBL] [Abstract][Full Text] [Related]
26. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
27. [An apparently primary lymphoma of the testicle].
Belbusti F; Signoretti P; Tondi MR; Sparaventi G
G Chir; 1991; 12(8-9):438-40. PubMed ID: 1721520
[TBL] [Abstract][Full Text] [Related]
28. Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies.
Pinnix CC
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):641-4. PubMed ID: 26972636
[No Abstract] [Full Text] [Related]
29. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
30. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
31. Treatment of localized lymphoma.
Hoecht S; Hinkelbein W
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
[No Abstract] [Full Text] [Related]
32. The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Connors JM
Important Adv Oncol; 1990; ():227-33. PubMed ID: 2182521
[No Abstract] [Full Text] [Related]
33. Is CHOP the standard of therapy for poor-prognosis large-cell lymphoma?
Canellos GP
Ann Oncol; 1997; 8 Suppl 1():61-2. PubMed ID: 9187432
[No Abstract] [Full Text] [Related]
34. CHOP and rituximab in elderly patients.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916
[No Abstract] [Full Text] [Related]
35. Diffuse large B-cell lymphoma.
Ng AK
Semin Radiat Oncol; 2007 Jul; 17(3):169-75. PubMed ID: 17591563
[TBL] [Abstract][Full Text] [Related]
36. Front-line management of diffuse large B cell lymphoma.
Cabanillas F
Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
[TBL] [Abstract][Full Text] [Related]
37. Treatment of localized lymphoma.
Adli M; Sevinc A; Kalender ME
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
[No Abstract] [Full Text] [Related]
38. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
39. Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up.
Ohnoshi T; Hayashi K; Ueno K; Tada A; Mizuta J; Tagawa S; Matsutomo S; Saito S; Kawashima K; Yoshino T
Int J Hematol; 1993 Aug; 58(1-2):93-8. PubMed ID: 7693030
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I].
Ueda K; Yokoyama M; Asai H; Koudaira M; Yamada S; Katsube A; Mishima Y; Sakajiri S; Takeuchi K; Saotome T; Terui Y; Takahashi S; Hatake K
Gan To Kagaku Ryoho; 2010 May; 37(5):853-7. PubMed ID: 20495315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
